The interferon-dependent orchestration of innate and adaptive immunity after transplantation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-06-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2012-02-368076PMID 22517908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

  2012cited by this paper
• IFN-γ promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation.

  2011cited by this paper
• The Two Faces of Interferon-γ in Cancer

  2011cited by this paper
• Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

  2011cited by this paper
• Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.

  2011cited by this paper
• Type I-IFNs control GVHD and GVL responses after transplantation.

  2011cited by this paper
• Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice.

  2011cited by this paper
• Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen.

  2011cited by this paper
• Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease

  2011cited by this paper
• IFN-λ determines the intestinal epithelial antiviral host defense

  2011cited by this paper
• Graft-versus-Host Disease Is Independent of Innate Signaling Pathways Triggered by Pathogens in Host Hematopoietic Cells

  2011cited by this paper
• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

  2010cited by this paper
• Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C

  2010cited by this paper
• Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

  2010cited by this paper
• Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections

  2010cited by this paper
• Preclinical and Clinical Development of Pegylated Interferon-Lambda 1 in Chronic Hepatitis C

  2010cited by this paper
• Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ

  2010cited by this paper
• Graft-versus-host disease.

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.

  2009cited by this paper
• IFNα activates dormant haematopoietic stem cells in vivo

  2009cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation.

  2009cited by this paper
• Induction of natural killer T cell–dependent alloreactivity by administration of granulocyte colony–stimulating factor after bone marrow transplantation

  2009cited by this paper
• Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

  2009cited by this paper
• Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.

  2009cited by this paper
• Dichotomous role of interferon-gamma in allogeneic bone marrow transplant.

  2009cited by this paper
• Interferon-alpha controls IL-17 expression in vitro and in vivo.

  2008cited by this paper
• Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin.

  2008cited by this paper
• Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.

  2008cited by this paper
• The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

  2008cited by this paper
• IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo

  2008cited by this paper
• Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.

  2008cited by this paper
• Type I Interferon Receptors: Biochemistry and Biological Functions*

  2007cited by this paper
• Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function1

  2007cited by this paper
• Haematopoietic stem cell transplantation: can our genes predict clinical outcome?

  2007cited by this paper
• Rearrangements of the Williams–Beuren syndrome locus: molecular basis and implications for speech and language development

  2007cited by this paper
• The role of type I interferons in TLR responses

  2007cited by this paper
• Interferons in multiple sclerosis: ten years' experience.

  2007cited by this paper
• IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.

  2007cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo

  2006cited by this paper
• Interferons, immunity and cancer immunoediting

  2006cited by this paper
• NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

  2005cited by this paper
• A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

  2005cited by this paper
• Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection

  2005cited by this paper
• Mechanisms of type-I- and type-II-interferon-mediated signalling

  2005cited by this paper
• Critical role of host γδ T cells in experimental acute graft-versus-host disease

  2005cited by this paper
• The Yin and Yang of type I interferon activity in bacterial infection

  2005cited by this paper
• Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction

  2005cited by this paper
• Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

  2005cited by this paper
• IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

  2005cited by this paper
• A critical function for type I interferons in cancer immunoediting

  2005cited by this paper
• Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

  2005cited by this paper
• Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.

  2005cited by this paper
• Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.

  2005cited by this paper
• Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease.

  2004cited by this paper
• Interferon- : an overview of signals, mechanisms and functions

  2004cited by this paper
• Interferon-gamma: an overview of signals, mechanisms and functions.

  2004cited by this paper
• Differential Requirement for IFN-γ in CTL Maturation in Acute Murine Graft-versus-Host Disease1

  2004cited by this paper
• Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9

  2004cited by this paper
• The Pathophysiology of Acute Graft-versus-Host Disease

  2003cited by this paper
• γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity

  2003cited by this paper
• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

  2003cited by this paper
• IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex

  2003cited by this paper
• IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

  2003cited by this paper
• Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.

  2002cited by this paper
• The roles of IFNγ in protection against tumor development and cancer immunoediting

  2002cited by this paper
• IL-28, IL-29 and their class II cytokine receptor IL-28R

  2002cited by this paper
• Interferon γ Is Required for Activation-induced Death of T Lymphocytes

  2002cited by this paper
• The roles of IFN gamma in protection against tumor development and cancer immunoediting.

  2002cited by this paper
• Interferon γ is required for activation-induced death of T lymphocytes

  2002cited by this paper
• Interferons alpha and beta as immune regulators--a new look.

  2001cited by this paper
• Interferons α and β as Immune Regulators—A New Look

  2001cited by this paper
• SOCS Proteins: Negative Regulators of Cytokine Signaling

  2001cited by this paper
• Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

  2001cited by this paper
• Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

  2001cited by this paper
• Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion

  2001cited by this paper
• Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.

  2001cited by this paper
• Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

  2001cited by this paper
• Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis

  2000cited by this paper
• Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma.

  2000cited by this paper
• Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.

  1999cited by this paper
• Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).

  1999cited by this paper
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999cited by this paper
• Interferon- Before Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure

  1999cited by this paper
• Mood and cognitive side effects of interferon-alpha therapy.

  1998cited by this paper
• Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase

  1998cited by this paper
• Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.

  1998cited by this paper
• Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.

  1998cited by this paper
• Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

  1998cited by this paper
• Mood and cognitive side effects of interferon-α therapy

  1998cited by this paper
• Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

  1998cited by this paper
• Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

  1997cited by this paper
• Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

  1997cited by this paper
• Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

  1996cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

  1995cited by this paper
• Immunol. Cell Biol.

  1995cited by this paper
• A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses.

  1995cited by this paper

• Inhibition of EZH2 by SHR2554 modifies subset ratios and suppresses polyfunctional responses of peripheral blood T cells from hematopoietic stem cell donors.

  2025cites this paper
• Hippobosca equina: Influences on oxidative stress and immune‐regulating cytokine responses in horses

  2025cites this paper
• The Aberrantly Expressed Nuclear Factor (Erythroid-derived 2)-Like 2 Participates in aGVHD by Modulating the Activation and Differentiation of CD4+ T Lymphocytes

  2025cites this paper
• Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury

  2025cites this paper
• Innovative diagnostic strategies for equine habronemiasis: exploring molecular identification, gene expression, and oxidative stress markers

  2025cites this paper
• Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice

  2024cites this paper
• Molecular and immunological studies on Theileria equi and its vector in Egypt

  2024cites this paper
• IFN-γ induces acute graft-versus-host disease by promoting HMGB1-mediated nuclear-to-cytoplasm translocation and autophagic degradation of p53

  2024cites this paper
• Gut-immunity modulation in Lepidocephalichthys guntea during Aeromonas hydrophila-infection and recovery assessed with transcriptome data

  2023cites this paper
• Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity

  2022cites this paper
• IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

  2022cites this paper
• Aryl hydrocarbon receptor-targeted therapy of CD4+ T-cell-mediated idiopathic pneumonia syndrome in mice.

  2022cites this paper
• The Signaling Pathways Regulating NLRP3 Inflammasome Activation

  2021cites this paper
• A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients

  2021influential citation
• T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor

  2021cites this paper
• The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations

  2021cites this paper
• PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.

  2020cites this paper
• Steroid‐refractory acute graft‐versus‐host disease graded III‐IV in pediatric patients. A mono‐institutional experience with a long‐term follow‐up

  2020influential citation
• T cell–derived interferon-γ programs stem cell death in immune-mediated intestinal damage

  2019cites this paper
• Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice

  2019cites this paper
• A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages

  2019cites this paper
• The regulation of interferon type I pathway‐related genes RSAD2 and ETV7 specifically indicates antibody‐mediated rejection after kidney transplantation

  2018cites this paper
• Rsad2 is necessary for mouse dendritic cell maturation via the IRF7-mediated signaling pathway

  2018cites this paper
• Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant

  2017cites this paper
• Cytokines in Hematopoietic Stem Cell Transplantation

  2017cites this paper
• Inhibition of 5-lipoxygenase alleviates graft-versus-host disease

  2017cites this paper
• Differential growth and responsiveness to cancer therapy of tumor cells in different environments

  2016cites this paper
• Role of the intestinal mucosa in acute gastrointestinal GVHD.

  2016cites this paper
• Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.

  2016cites this paper
• Role of the intestinal mucosa in acute gastrointestinal GVHD.

  2016cites this paper
• TRANSPLANTATION Programming of donor T cells using allogeneic d -like ligand 4 – positive dendritic cells to reduce GVHD in mice

  2016cites this paper
• Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance

  2015influential citation
• Targeting T-bet for Prevention of Graft-Versus-Host Disease and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

  2015influential citation
• Mechanisms of graft-versus-host-disease: a role for Langerhans cells in regulating skin GVHD

  2015cites this paper
• T-bet Is Critical for the Development of Acute Graft-versus-Host Disease through Controlling T Cell Differentiation and Function

  2015cites this paper
• Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-versus-Host Disease and Preserves Anti-Tumor Effects

  2015cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma

  2015cites this paper
• Immunotherapy following relapse of acute leukaemia after T‐cell‐replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft‐versus‐host disease

  2014cites this paper
• Controlling T Cell Differentiation and Acute Graft-versus-Host Disease through T-bet Is Critical for the Development of

  2014cites this paper
• Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation

  2014cites this paper
• Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

  2014cites this paper
• The biology of graft-versus-host disease: experimental systems instructing clinical practice.

  2014cites this paper
• The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment

  2014cites this paper
• ADVANCES IN HEMATOPOIETIC CELL TRANSPLANTATION The biology of graft-versus-host disease: experimental systems instructing clinical practice

  2014cites this paper
• Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

  2014cites this paper
• Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD.

  2014influential citation
• Current World Literature

  2013cites this paper
• Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-α2b and granulocyte-macrophage colony-stimulating factor

  2013cites this paper
• Lithothamnion muelleri Controls Inflammatory Responses, Target Organ Injury and Lethality Associated with Graft-versus-Host Disease in Mice

  2013cites this paper
• A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT

  2013cites this paper
• IFNγR signaling mediates alloreactive T-cell trafficking and GVHD.

  2012cites this paper